CytomX Therapeutics (CTMX) Leases (2017 - 2025)
Historic Leases for CytomX Therapeutics (CTMX) over the last 9 years, with Q3 2025 value amounting to $4.8 million.
- CytomX Therapeutics' Leases fell 4763.41% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 4763.41%. This contributed to the annual value of $8.1 million for FY2024, which is 3342.06% down from last year.
- Per CytomX Therapeutics' latest filing, its Leases stood at $4.8 million for Q3 2025, which was down 4763.41% from $5.9 million recorded in Q2 2025.
- CytomX Therapeutics' 5-year Leases high stood at $21.7 million for Q1 2021, and its period low was $4.8 million during Q3 2025.
- Over the past 5 years, CytomX Therapeutics' median Leases value was $14.1 million (recorded in 2023), while the average stood at $13.8 million.
- Per our database at Business Quant, CytomX Therapeutics' Leases tumbled by 1193.58% in 2021 and then crashed by 4763.41% in 2025.
- Quarter analysis of 5 years shows CytomX Therapeutics' Leases stood at $19.4 million in 2021, then decreased by 17.63% to $15.9 million in 2022, then fell by 23.38% to $12.2 million in 2023, then plummeted by 33.42% to $8.1 million in 2024, then plummeted by 40.83% to $4.8 million in 2025.
- Its last three reported values are $4.8 million in Q3 2025, $5.9 million for Q2 2025, and $7.1 million during Q1 2025.